FDA Rejects Replimune’s Melanoma Therapy Again Citing Unaddressed Study Concerns, Fueling Industry Debate
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Knowledge and News for the Global Fight Against Cancer.
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant...
A groundbreaking study published on April 1, 2026, in Neurology Open Access, the official journal...
The clinical journey for Macon began not with an emergency room visit or a sudden...
The start of a new school year is traditionally marked by a sense of renewal...
Lumanity’s Cancer Progress 2026, held on April 9th at the New York Genome Center, served...
A groundbreaking study conducted by a collaborative team of Canadian researchers has unveiled a significant...
The groundbreaking research, spearheaded by scientists from Flinders University and Greifswald University, has revealed that...
Researchers at Flinders University and Flinders Medical Centre have identified a critical connection between two...
A groundbreaking study, published in the prestigious journal Nature Communications, is shedding new light on...